JANE STREET GROUP, LLC - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 173 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,609,363
+673.8%
144,079
+1382.4%
0.00%
Q2 2023$207,987
-74.5%
9,719
-51.9%
0.00%
Q1 2023$816,322
+245.9%
20,186
+539.4%
0.00%
Q4 2021$236,000
-62.6%
3,157
-71.6%
0.00%
Q3 2021$631,000
+58.1%
11,100
+22.5%
0.00%
Q2 2021$399,000
+99.5%
9,060
+90.6%
0.00%
Q4 2020$200,000
-24.2%
4,753
-17.6%
0.00%
Q3 2020$264,000
+26.9%
5,767
+39.5%
0.00%
Q2 2020$208,000
-30.2%
4,135
-14.3%
0.00%
Q4 2019$298,000
-15.6%
4,826
-17.9%
0.00%
-100.0%
Q3 2019$353,000
+69.7%
5,880
+138.8%
0.00%
Q2 2019$208,000
-45.3%
2,462
-54.1%
0.00%
-100.0%
Q4 2018$380,000
-63.6%
5,364
-40.4%
0.00%
-50.0%
Q2 2018$1,043,000
+340.1%
9,000
+50.5%
0.00%0.0%
Q3 2014$237,000
-49.3%
5,981
-44.9%
0.00%
-66.7%
Q2 2014$467,00010,8510.01%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 1,055,719$35,367,00012.68%
GREAT POINT PARTNERS LLC 828,253$27,746,0005.70%
McClain Value Management LLC 116,153$3,891,0004.80%
Stonepine Capital Management, LLC 231,913$7,769,0004.63%
ARMISTICE CAPITAL, LLC 228,000$7,638,0001.81%
Opaleye Management Inc. 90,000$3,015,0001.78%
Matarin Capital Management, LLC 257,268$8,618,478,0000.97%
HAYS ADVISORY LLC 116,939$3,917,0000.87%
Granahan Investment Management 496,025$16,617,0000.57%
AlphaMark Advisors, LLC 33,000$1,106,0000.57%
View complete list of ENANTA PHARMACEUTICALS INC shareholders